Browse wiki

ANSI/ANS-15.16-2015 +, ANSI/ANS-15.8-1995 +, ANSI/ANS-15.1-2007 +, ANSI/ANS-15.4-2016 +, ANSI/ANSI-15.8-1995 +, ANSI/ANS15.4-2016 +, ANSI/ANS--15.1-2007 +  and ANSI/ANS-5.4-2016 +

Iodine +, Uranium +, Nitrogen +, Carbon +, Hydrogen +, Lead +  and Plutonium +

10 CFR 55 +, 10 CFR 20 +, 10 CFR 74.11 +, 10 CFR 50 +, 10 CFR 70 +, 10 CFR 21.3 +, 10 CFR 50.36 +, 10 CFR 73.71 +, 10 CFR 50.2 +, 10 CFR 37 +, 10 CFR 73 +, 10 CFR 75 +, 10 CFR 21.7 +, 10 CFR 19.12 +, 10 CFR 20.1502 +, 10 CFR 50.31 +, 10 CFR 50.40 +, 10 CFR 50.57 +, 10 CFR 50.74 +, 10 CFR 50.90 +, 10 CFR 55.4 +, 10 CFR 55.11 +, 10 CFR 55.21 +, 10 CFR 55.31 +, 10 CFR 55.40 +, 10 CFR 55.41 +, 10 CFR 55.43 +, 10 CFR 55.45 +, 10 CFR 55.46 +, 10 CFR 55.47 +...

Emergency Preparedness +  and Physical Protection +

Regulatory Guide 2.6 +, Regulatory Guide 5.59 +, ML062190191 +, Regulatory Guide 2.5 +, ML15198A217 +, ML15176A258 +, ML13269A378 +, ML17018A218 +, ML19211C144 +, ML19211C141 +, ML21076A519 +, ML21307A306 +, ML21315A003 +, ML21320A066 +, ML21350A191 +, ML21350A190 +, ML22164A053 +, ML22223A066 +, ML22202A451 +  and NUREG-2189, Safety Evaluation Report - Related to Shine Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility +

Michael Balazik +  and NRC/NRR/DANU/UNPL +

ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +, ML22316A053 +  and ML22316A053 +

Tritium +, U-235 +, Uranium-233 +  and Mo-99 +

DOE/NRC Form 742 +  and NRC Form 327 +

NUREG-1262, Discusses Review of Plant Simulation Facility Development Plan,Submitted on 880526.Overall Approach of Plan Acceptable Due to Reliance on Util Simulation Facility Group Baseline Document.Issues Requiring Resolution Stated +, NUREG-0849, Informs That General Atomics Radiological Contingency Plan for Training & Familiarization Onsite for Offsite Response Organizations Acceptable & Approved by Nrc.Changes Were Revised Using NUREG-0849 +, NUREG-1520, Recommends That 980504 Avlis Licensing Process License Application Be One Document W/O Part I/Part II Distinction. Staff Recommended Example of Application & Environ Rept Format,Encl +, NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report +  and NUREG-2189, Safety Evaluation Report - Related to Shine Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility +

Regulatory Guide 2.6 +, Regulatory Guide 5.59 +  and Regulatory Guide 2.5 +

TS-5.1.4 +, TS-5.1.3 +, TS-5.9.3 +, TS-5.9.2 +, TS-5.8.4 +  and TS-5.2.4.1 +

Piefer G +  and SHINE Technologies +

Fitness for Duty +, Commercial Grade Dedication +, Exemption Request +, Earthquake +, Commercial Grade +, Pressure boundary leak +, Grace period +  and Basic Component +